Catch up on news and events from the medical aesthetic industry around the globe. Join the mailing list to get the latest updates, including free webinars, practice enhancement tips, educational resources, and more.
TORONTO, August 15, 2019 (PRNewswire) – Venus Concept Ltd. (“Venus Concept”), a privately-held global medical aesthetic technology leader, provided unaudited financial results for the second quarter and first six months of 2019.
For more information call: +27 31 535 7241 // firstname.lastname@example.org
REGULATORY CLEARANCES [ More ]
The Venus Freeze Plus, Venus Legacy, Venus Viva and Venus Versa has the following CE marketing of conformity: Non-invasive dermatological treatment system for non-invasive body circumference reduction, cellulite reduction, wrinkle reduction, acne reduction (acne vulgaris), skin tightening treatment, superficial benign vascular and pigmented lesions treatments, and treatment of hirsutism (hair removal)
Venus Glow™ is listed by the FDA as a Class I device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.